Educating Patients With Endometrial Cancer on Treatment-Related Adverse Events

Approvals in oncology during April included treatments for breast cancer, colorectal cancer, and more.

Lauren Mahon, MSN, FNP-BC, breaks down what oncology nurses should know about PARP inhibitors in ovarian cancer.

The PRECURSOR intervention appeared feasible/acceptable, suggesting a need for patient-centered conversation in incurable gynecologic cancer treatment.

In this episode of The Vitals, we recount the oncology drugs that received FDA approvals in 2022.

The FDA approved bevacizumab-nwgd across several gastrointestinal, gynecological, brain, and lung cancer types.

Oncology nurses can enhance endometrial cancer recovery by fostering strong social support networks and improving communication with the patient.